Swiss stocks - Factors to watch on August 24

Centiel AG

24/08/2020 05:42

ZURICH/BERLIN, Aug 24(Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
    
    NOVARTIS  NOVN.S 
    Swiss drugmaker Novartis said on Saturday that its
investigational spartalizumab immuno-oncology drug mixed with
the approved medicines Tafinlar and Mekinist failed in a
late-stage trial for a type of advanced skin cancer.
 urn:newsml:reuters.com:*:nFWN2FN0G2
    
    ANALYSTS' VIEWS
    HOCHDORF HOLDING AG  HOCN.S : CREDIT SUISSE CUTS TARGET
PRICE TO CHF 55 FROM CHF 65
    FLUGHAFEN ZUERICH AG  FHZN.S : RBC RAISES TARGET PRICE TO
CHF 145 FROM CHF 140
    
    ECONOMY
    SNB sight deposits due at 0800 GMT.
    

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))